Cochrane Review Group
Stroke
108 systematic reviews in Stroke ask 1,248 questions. 22% have no studies to answer them, 21.6% rest on very low certainty evidence and 24% reach moderate or high certainty.
Reviews
108
Questions
1,248
current versions
No studies
22%
Moderate or high
24%
No studies 275 · 22%Ungraded 56 · 4.5%Very low 269 · 21.6%Low 349 · 28%Moderate 216 · 17.3%High 83 · 6.7%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Pharmacological interventions vs placebo Depression: meeting study criteria for depression at end of treatment (primary outcome) · people with depression after stroke Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane | RR 0.7 [0.55, 0.88] | 8 studies · 1025 participants | Very low |
Non‐invasive brain stimulation vs sham non‐invasive brain stimulation and/or usual care Depression: mean scores at end of treatment (secondary outcome) · people with depression after stroke Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane | no estimate extracted | 8 studies · 505 participants | Very low |
Psychological therapy vs usual care and/or attention control Depression: meeting study criteria for depression at end of treatment (primary outcome) · people with depression after stroke Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane | RR 0.77 [0.62, 0.95] | 6 studies · 521 participants | Very low |
Psychological therapy vs usual care and/or attention control Depression: meeting study criteria for depression at end of · people with depression after stroke Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane | RR 0.85 [0.59, 1.21] | 3 studies · 201 participants | Very low |
Psychological therapy vs usual care and/or attention control Adverse events: death ‐ at end of treatment (secondary outcome) · people with depression after stroke Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane | RR 0.65 [0.26, 1.66] | 9 studies · 889 participants | Very low |
Pharmacological interventions vs placebo Depression: < 50% reduction in scale scores at end of treatment (primary outcome) · people with depression after stroke Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane | RR 0.48 [0.32, 0.7] | 6 studies · 511 participants | Very low |
Psychological therapy vs usual care and/or attention control Adverse events: all ‐ central nervous system events (e.g. suicidal intentions) (secondary outcome) · people with depression after stroke Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane | RR 0.87 [0.2, 3.9] | 2 studies · 126 participants | Very low |
Psychological therapy vs usual care and/or attention control Adverse events: all ‐ other events ‐ not listed above (e.g. fall, too ill) (secondary outcome) · people with depression after stroke Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane | RR 0.62 [0.13, 3.09] | 3 studies · 254 participants | Very low |
Pharmacological intervention and psychological therapy (combination) vs a pharmacological intervention and usual care or attention control (single) Depression: mean scores at end of treatment (secondary outcome) · people with depression after stroke Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane | no estimate extracted | 3 studies · 278 participants | Very low |
Pharmacological intervention and non‐invasive brain stimulation (combination) vs a pharmacological intervention and sham stimulation or usual care (single) Depression: < 50% reduction in scale scores at end of treatment (primary outcome) · people with depression after stroke Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane | RR 0.95 [0.69, 1.3] | 3 studies · 392 participants | Very low |
Pharmacological intervention and non‐invasive brain stimulation (combination) vs a pharmacological intervention and sham stimulation or usual care (single) Depression: mean scores at end of treatment (secondary outcome) · people with depression after stroke Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane | no estimate extracted | 12 studies · 1055 participants | Very low |
Pharmacological intervention and non‐invasive brain stimulation (combination) vs a pharmacological intervention and sham stimulation or usual care (single) Adverse events: death (secondary outcome) · people with depression after stroke Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for… (2023) · Cochrane | RR 1.06 [0.27, 4.16] | 5 studies · 487 participants | Very low |
Reviews 108
Activity monitors for increasing physical activity in adult stroke survivors
CochraneSoF table
10 questions
Low‐molecular‐weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke
CochraneSoF table
5 questions
Nitric oxide donors (nitrates), L‐arginine, or nitric oxide synthase inhibitors for acute stroke
CochraneSoF table
7 questions
Early supported discharge services for people with acute stroke
CochraneSoF table
7 questions
Interventions for dysarthria due to stroke and other adult‐acquired, non‐progressive brain injury
CochraneSoF table
6 questions
Treadmill training and body weight support for walking after stroke
CochraneSoF table
7 questions
Occupational therapy for adults with problems in activities of daily living after stroke
CochraneSoF table
4 questions
Music interventions for acquired brain injury
CochraneSoF table
7 questions
Circuit class therapy for improving mobility after stroke
CochraneSoF table
6 questions
Virtual reality for stroke rehabilitation
CochraneSoF table
9 questions
Interventions for treating anxiety after stroke
CochraneSoF table
7 questions
Yoga for stroke rehabilitation
CochraneSoF table
9 questions
Speech and language therapy for aphasia following stroke
CochraneSoF table
16 questions
Cognitive rehabilitation for memory deficits after stroke
CochraneSoF table
10 questions
Acupuncture for stroke rehabilitation
CochraneSoF table
16 questions
Puerarin for ischaemic stroke
CochraneSoF table
2 questions
Repetitive task training for improving functional ability after stroke
CochraneSoF table
8 questions
Intraoperative mild hypothermia for postoperative neurological deficits in people with intracranial aneurysm
CochraneSoF table
7 questions
Pharmacological interventions other than botulinum toxin for spasticity after stroke
CochraneSoF table
2 questions
Self management programmes for quality of life in people with stroke
CochraneSoF table
4 questions
Caregiver‐mediated exercises for improving outcomes after stroke
CochraneSoF table
7 questions
Immediate versus delayed treatment for recently symptomatic carotid artery stenosis
CochraneSoF table
4 questions
Interventions for post‐stroke fatigue
CochraneSoF table
5 questions
Buflomedil for acute ischaemic stroke
CochraneSoF table
5 questions
Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack
CochraneSoF table
12 questions